| Field | Specification |
|---|---|
| Mfr No | |
| Accession Number | |
| Alternative Names | Aquaporin 4, Aquaporin-4, AQP4, AQP-4, AQP 4, AQP4_HUMAN, Aquaporin type 4, Aquaporin4, HMIWC 2, HMIWC2, Mercurial insensitive water channel, Mercurial-insensitive water channel, MGC22454, MIWC, WCH 4, WCH4 |
| Cellular Localization | |
| Clonality | |
| Concentration | |
| Host | |
| Immunogen | Produced against the C-terminal peptide (Sequence N-CTKGSYMEVEDNRSQVETED) of rat aquaporin 4 |
| Product Type | |
| Reactivity | |
| Shipping | |
| Storage | |
| Target |
Aquaporin 4 (AQP4) is a key water channel protein predominantly expressed in the central nervous system, where it plays a critical role in maintaining brain water balance. While it is also found in the basolateral membrane of renal collecting duct cells, its most significant physiological and pathological functions are observed in the brain, particularly in astrocyte endfeet at the blood-brain barrier and around brain ventricles.
AQP4 facilitates bidirectional water transport in response to osmotic gradients, contributing to cerebrospinal fluid dynamics, neurovascular coupling, and the clearance of metabolic waste via the glymphatic system. Its expression is rapidly upregulated in response to central nervous system (CNS) injury, including trauma, ischemia, and neuroinflammation, making it a key player in the development of cerebral edema and gliosis.
Importantly, AQP4 is the primary autoimmune target in neuromyelitis optica spectrum disorder (NMOSD), a severe inflammatory demyelinating disease of the CNS. Autoantibodies against AQP4 (AQP4-IgG) lead to astrocyte damage, blood-brain barrier disruption, and secondary neuronal injury.
Beyond NMOSD, dysregulation of AQP4 has been implicated in Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis, where impaired water clearance and neuroinflammation contribute to disease progression. As such, AQP4 is increasingly recognized as a promising biomarker and therapeutic target in neurodegenerative disease research.
0.5 µg/ml of SPC-505 was sufficient for detection of aquaporin 4 in 10 µg of rat kidney tissue lysate by colorimetric immunoblot analysis using Goat anti-rabbit IgG:HRP as the secondary antibody.
Cite this product varies by variant:
- SPC-505D — Size: 100 ug: Aquaporin 4 Antibody (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SPC-505D, RRID: AB_10963604)
- SPC-505D-A390 — Size: 100 ug: Aquaporin 4 Antibody: ATTO 390 (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SPC-505D-A390, RRID: AB_2704658)
- SPC-505D-A488 — Size: 100 ug: Aquaporin 4 Antibody: ATTO 488 (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SPC-505D-A488, RRID: AB_2704659)
- SPC-505D-A594 — Size: 100 ug: Aquaporin 4 Antibody: ATTO 594 (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SPC-505D-A594, RRID: AB_2704661)
- SPC-505D-APC — Size: 100 ug: Aquaporin 4 Antibody: APC (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SPC-505D-APC, RRID: AB_2704667)
- SPC-505D-BI — Size: 100 ug: Aquaporin 4 Antibody: Biotin (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SPC-505D-BI, RRID: AB_2704668)
- SPC-505D-FITC — Size: 100 ug: Aquaporin 4 Antibody: FITC (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SPC-505D-FITC, RRID: AB_2704669)
- SPC-505D-HRP — Size: 100 ug: Aquaporin 4 Antibody: HRP (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SPC-505D-HRP, RRID: AB_2704670)
- SPC-505D-PCP — Size: 100 ug: Aquaporin 4 Antibody: PerCP (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SPC-505D-PCP, RRID: AB_2704672)
- SPC-505D-RPE — Size: 100 ug: Aquaporin 4 Antibody: RPE (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SPC-505D-RPE, RRID: AB_2704673)
- SPC-505S — Size: 12 ug: Aquaporin 4 Antibody (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SPC-505S, RRID: AB_10963604)
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
2. Knepper M.A. (1994) Proc Natl. Acad Sci. USA. 91(14): 6255-6258.
3. Agre P., Nielsen S. (1996) Nephrologie. 17(7): 409-415.
4. Nagelhus E.A., Mathiisen T.M., Ottersen O.P. (2004) Neuroscience. 129(4): 905-913.
5. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., Hinson S.R. (2005) J Exp Med. 202(4): 473-477.
6. Bradl M., Lassmann D.H. (2008) Int. MS Journal/MS Forum. 15(3): 75-78.